Retraction

A Pan-Cancer Analysis of the Role of PBRM1 in Human Tumors

Citations (5)

5
Total Citations
3
Post-Retraction
(60.0%)
1
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
2 Within 1 year
0 After 2+ years
391 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
PBRM1 deficiency enhances PD1 immunotherapeutic sensitivity via chromosomal accessibility in colorectal cancer
Rui Li, Jie He, Chaoqun Liu et al. (8 authors)
Theranostics Open Access
Published: Feb 2025
1 citation
391 days after retraction
THE GENOMIC LANDSCAPE OF THE SWITCH/SUCROSE NON-FERMENTABLE CHROMATIN REMODELING COMPLEX IN ACUTE MYLEOID LEUKEMIA
Didem Özkan, Dilara Fatma Akın
Sağlık Bilimleri Dergisi Open Access
Published: Jul 2024
168 days after retraction
PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer
Norman Fultang, Ashley M. Schwab, Sophia McAneny-Droz et al. (9 authors)
Frontiers in Oncology Open Access
Published: Feb 2024
2 citations
9 days after retraction
Retracted: A Pan-Cancer Analysis of the Role of PBRM1 in Human Tumors
Stem Cells International
Stem Cells International Open Access
Published: Jan 2024
23 days before retraction
Quick Stats
Total Citations: 8
Years Since Retraction: 1.8 year
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
MiR-23a-3p acts as an oncogene and potential prognostic bio…
Biomedicine & Pharmacotherapy • 41 citations
LINC00511 Promotes Osteosarcoma Tumorigenesis and Invasiven…
BioMed Research International • 0 citations
Increased EHHADH Expression Predicting Poor Survival of Ost…
BioMed Research International • 0 citations
Loading Gentamicin and Zn2+ on TiO2 Nanotubes to Improve An…
Stem Cells International • 15 citations